Smith & Nephew plc Stock Price and Value Analysis

Should you buy Smith & Nephew plc stock? (NYSE:SNN). Let's see how it does in our automated value investing analysis system.

  • This company has a large dividend yield!
  • This company has amazingly consistent growth!
  • This company is not making money.
  • This company is less known than others.
  • This stock looks overpriced.

Inside the SNN Numbers

SNN Price
(Smith & Nephew plc stock price per share)
[?] PE Ratio versus Sector 30% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Medical Devices stocks
[?] Free Cash Flow Jitter 0%
[?] Dividend Yield 3%
Shares Shorted 3,900,097

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 3,900,097 shares shorted. With 434,780,346 shares available for purchase and an average trading volume over the past 10 trading days of 738,230, it would take at least 5.283 days for all of the short holders to cover their shorts.

Is Smith & Nephew plc Stock on Sale?

Based on our analysis, we believe that you should not buy Smith & Nephew plc right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy SNN Stock?

Does Smith & Nephew plc have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.